Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Merck KGaA CEO: Israel has so much talent and ability
#Customers #Investment #Acquisition
Jun 13, 2022
Larisa Amir appointed Managing Director of Merck R&D Center in Israel CTech
Dec 8, 2021
Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million Merck
Jun 23, 2020
Startup from Merck Innovation Lab in Israel Markets First Predictive Maintenance Sensors Merck
Feb 12, 2019
German drugmaker Merck sets up Israel incubator to tap into chip, sensor tech
Feb 21, 2018
Merck sets up €20m fund for Israeli biotech cos
Aug 23, 2017
Merck KGaA Sets Up PMatX Incubator in Israel for Next-Generation Electronics
Feb 16, 2016
Merck extends Weizmann Institute partnership
Jun 30, 2015
Merck CEO sees firm's future intertwined with Israel's
Apr 18, 2012
Merck Serono opens Israeli drug development incubator
Merck operates in the areas of healthcare, life science and electronics, with around 58,000 employees in 66 countries. All three business sectors of Merck have R&D activities in Israel, and are actively promoting Sustainability in all areas.
Inter-Lab - Mercks healthcare R&D center in Yavne. Inter-Lab can be credited with a great achievement in the pharmaceutical world; the development and production of the active ingredient in Rebif, an advanced treatment for multiple sclerosis. Currently the teams are involved in the development of novel antibody-based treatments for cancer and immuno-oncology therapies. Since 1996, Mercks biopharmaceutical sales and marketing activities in Israel are led by the team of Merck-Serono Ltd. in Herzliya.
The Life Science business of Merck is represented in Israel by the acquired Sigma-Aldrich global company. R&D, production, sales and distribution activities operate in three state-of-the-art facilities, one in Rehovot and two in Jerusalem.
Electronics R&D of semiconductor solutions is represented in Jerusalem at the Qlight site, while DS&S supplies specialty gases to Intel Kiryat Gat and other IL customers